Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025
   EV/Core EBITDA(x) 11.348.70

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202611.34
Mar20258.70

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 11.34
30.34
Mar2025 8.7 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹1,576.1 Cr 4.1% 9.8% 253.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,815.0 Cr 0.5% 6.2% 17.3% Stock Analytics
DIVIS LABORATORIES ₹192,678.0 Cr 4.7% 9% 7% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,323.0 Cr -3.7% 7.2% 49.8% Stock Analytics
CIPLA ₹114,585.0 Cr -0.6% 5% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,067.0 Cr -1.9% -4.6% -2.8% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

4.1%

9.8%

253.1%

SENSEX

0.8%

1.8%

-6.5%


You may also like the below Video Courses